Soumen Bhattacharyya: Clinical Implications and Risks in Metformin-Induced Vitamin B12 Deficiency
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Metformin, Vitamin B12 Deficiency and Homocysteine: An Overlooked Clinical Link.
Metformin remains the cornerstone therapy for due to its efficacy, safety, and cardiovascular benefits.
However, an important long-term adverse effect often goes under-recognized: vitamin B12 deficiency and its metabolic consequences.
What’s the mechanism?
Metformin interferes with the calcium-dependent absorption of the intrinsic factor–vitamin B12 complex in the terminal ileum.
Additional contributing factors include altered gut motility and possible bacterial overgrowth.
Over time, this leads to reduced serum B12 levels.
Why does this matter?
Vitamin B12 plays a critical role in the conversion of homocysteine to methionine.
When B12 levels fall:
- Homocysteine accumulates
- Leads to a state of hyperhomocysteinemia
Clinical implications:
- Peripheral neuropathy (may mimic or worsen diabetic neuropathy)
- Megaloblastic anemia
- Increased cardiovascular risk associated with elevated homocysteine
What does the evidence say?
- Long-term metformin therapy is significantly associated with reduced B12 levels (de Jager et al., 2010)
- Reviews highlight impaired absorption as the primary mechanism (Niafar et al., 2021)
- Systematic analyses show increased homocysteine, particularly without vitamin supplementation (Aroda et al., 2016)
Clinical takeaway:
- Consider periodic monitoring of vitamin B12 in long-term metformin users
- Supplementation (oral or parenteral) when deficiency is detected
- Evaluate unexplained neuropathy carefully—don’t attribute everything to diabetes
Key References:
- de Jager J et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ, 2010.
- Niafar M et al. Long-term metformin therapy and vitamin B12 deficiency. (Review, PMC8311483)
- Aroda VR et al. Metformin and vitamin B12 deficiency: a systematic review.
A simple intervention—monitoring B12—can prevent significant morbidity in millions of patients on metformin.”

Stay updated with Hemostasis Today.
-
May 11, 2026, 01:38Heghine Khachatryan: The Emerging Era of Immunothrombosis and Precision Vascular Medicine
-
May 10, 2026, 18:07Recurrent DVT and PE in Young Adults May Indicate an Underlying Cause – The Lancet Group
-
May 10, 2026, 18:06Noemi Zampatti: Pediatric Celiac Crisis Complicated by Refeeding Syndrome and Proposed Diagnostic Criteria
-
May 10, 2026, 18:05Giovanni Solimeno: When the Common Femoral Artery Wall is Diseased, Closure is Not a Step
-
May 10, 2026, 18:04Maitri Vaishnav: The Bombay Blood Group and the Critical Role of the H Antigen
-
May 10, 2026, 18:03Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026